EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 13,000
-250 (-1.89%)
Oct 10, 2025, 3:30 PM KST
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 476.12 billion as of October 10, 2025. Its market cap has increased by 29.41% in one year.
Market Cap
476.12B
Enterprise Value
n/a
Revenue
96.04B
Ranking
n/a
PE Ratio
19.15
Stock Price
13,000.00
Market Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 476.12B, an increase of 287.54%. That is a compound annual growth rate of 16.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 476.12B | 7.26% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1,271.41B | 93.99% |
| Dec 30, 2020 | 655.40B | 209.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |